AFP and neoplasm: Serum alpha-fetoprotein (AFP) is the most widely used tumor marker for early screening and surveillance progression of HCC, nevertheless, it has unsatisfactory performance with a sensitivity of only 60% and specificity of only 80% (4, 5).